|
ERGIC2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.396500E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.134380E-01 |
| Normal-vs-Stage2 |
1.959760E-01 |
| Normal-vs-Stage3 |
1.475630E-03 |
| Normal-vs-Stage4 |
4.223600E-02 |
| Stage1-vs-Stage2 |
5.869400E-01 |
| Stage1-vs-Stage3 |
6.704800E-03 |
| Stage1-vs-Stage4 |
4.355600E-02 |
| Stage2-vs-Stage3 |
1.669030E-01 |
| Stage2-vs-Stage4 |
2.254600E-01 |
| Stage3-vs-Stage4 |
8.504200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.317500E-03 |
| Normal-vs-AfricanAmerican |
6.278800E-03 |
| Normal-vs-Asian |
2.899800E-01 |
| Caucasian-vs-AfricanAmerican |
4.443400E-01 |
| Caucasian-vs-Asian |
6.501400E-01 |
| AfricanAmerican-vs-Asian |
8.463000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.294000E-02 |
| Normal-vs-Female |
1.09780000001614E-06 |
| Male-vs-Female |
1.70616999999318E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.181450E-01 |
| Normal-vs-Extreme_Weight |
2.350200E-01 |
| Normal-vs-Obese |
3.823000E-03 |
| Normal-vs-Extreme_Obese |
6.944000E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.356200E-01 |
| Normal_Weight-vs-Obese |
2.672000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.758400E-01 |
| Extreme_Weight-vs-Obese |
4.616200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.144400E-01 |
| Obese-vs-Extreme_Obese |
3.113000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.698600E-03 |
| Normal-vs-Age(41-60Yrs) |
4.384100E-04 |
| Normal-vs-Age(61-80Yrs) |
1.633600E-01 |
| Normal-vs-Age(81-100Yrs) |
6.085800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.098200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.208300E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.899960E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.852270E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.777440E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.844400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.611800E-02 |
| Normal-VS-Type2 PRCC |
9.030000E-02 |
| Normal-VS-KIRP CIMP |
4.283100E-03 |
| Normal-VS-Unclassified PRCC |
1.703950E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.591000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.78126000000001E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
1.671390E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.10909999999576E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
1.420430E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.971500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.681600E-01 |
| Normal-vs-N1 |
6.790800E-04 |
| Normal-vs-N2 |
8.49600000000228E-05 |
| N0-vs-N1 |
1.902980E-03 |
| N0-vs-N2 |
1.941500E-02 |
| N1-vs-N2 |
9.425000E-01 |
|
|
